ADHD 2
Treatment:
o Medication
Ritalin (methylphenidate)
First-line treatment option
Stimulant – amphetamine derivative
Reduces activity/improves cognition in ADHD
Increase in dopamine
Risk of addiction and substance use
Atomoxetine
Selective noradrenaline reuptake inhibitor (SNRI)
Inhibits NET function
Non-stimulant
Lower risk of abuse
Targeted at dopamine/noradrenaline
o Behaviour modifications
o Life style changes
o Parental training
Improving coping strategies
o Academic interventions
Positive reinforcement
Restructuring learning
Increased praise
o Peer-related interventions
Treatment:
o Medication
Ritalin (methylphenidate)
First-line treatment option
Stimulant – amphetamine derivative
Reduces activity/improves cognition in ADHD
Increase in dopamine
Risk of addiction and substance use
Atomoxetine
Selective noradrenaline reuptake inhibitor (SNRI)
Inhibits NET function
Non-stimulant
Lower risk of abuse
Targeted at dopamine/noradrenaline
o Behaviour modifications
o Life style changes
o Parental training
Improving coping strategies
o Academic interventions
Positive reinforcement
Restructuring learning
Increased praise
o Peer-related interventions
